COVID-19 Ch 11: Modeling

COVID-19 Ch 11: Modeling

The eleventh episode of our Anatomy of a Pandemic series has arrived, and just in time. Have you found yourself trying to sift through headlines claiming “this model predicts that” and “that model predicts this”, but you’re not sure where the truth really lies? Then this episode is for you. With the help of Dr. Mike Famulare from the Institute for Disease Modeling (interview recorded April 29, 2020), we walk through the basics of mathematical modeling of infectious disease, explore some of the current projections for this pandemic, and discuss some guidelines for evaluating these headline-making models. As always, we wrap up the episode by discussing the top five things we learned from our expert. To help you get a better idea of the topics covered in this episode, we’ve listed the questions below:

  1. What is a math model and what are some of the goals of mathematical modeling?
  2. So talking specifically now about infectious disease models, can you walk us through what the basic components are of an infectious disease model, like an SIR model?
  3. Where do you get the data that you use to estimate the parameters in an SIR model - what is based on actual data and what has to be estimated?
  4. Infectious disease outbreaks often have a curve-like shape, with the number of infected individuals on the y-axis and time on the x-axis. Can you explain why infectious disease epidemics tend to follow a curve?
  5. Can you talk us through some of the assumptions that you have to make when you're constructing one of these models and how that kind of relates to the uncertainty inherent within models? How might that uncertainty affect interpretation?
  6. What are some examples of the various ways we use infectious disease models in public health policy? Can you talk about how models might be used at various stages of a pandemic to guide public health measures? How might our use of models early on in a pandemic be different from the middle of one?
  7. Speaking specifically about COVID-19 now, can you talk about what a basic model for this pandemic might look like?
  8. Are models for COVID-19 using only lab-confirmed cases of the disease or clinical-confirmed cases as well?
  9. Looking back on these earlier models of COVID-19, what can we take away from the performance of these models?
  10. Is there any agreement among models as to what policies might be the best in terms of keeping cases and deaths as low as possible?
  11. For those of us who have no background in mathematical or statistical modeling, are there guidelines that we should use to evaluate these models or compare them? What should we (as in the general public) be taking away from these models?
  12. Are there any positive changes you hope to see come out of this pandemic, either as a member of the community or as a math modeler?

For a deeper dive into the wonderful world of infectious disease models, we recommend checking out this recent video from Robin Thompson, PhD of Oxford Mathematics titled “How do mathematicians model infectious disease outbreaks?” The video was posted on April 8, 2020.

See omnystudio.com/listener for privacy information.

Jaksot(279)

Ep 205 Cancer Part 4: Where do things stand today?

Ep 205 Cancer Part 4: Where do things stand today?

For the entirety of our species’ history, our approach to cancer has largely been to react, to design new therapies and better combinations of treatments. This energy has certainly been well-spent, bu...

31 Maalis 1h 19min

Ep 204 Cancer Part 3: How do we treat it?

Ep 204 Cancer Part 3: How do we treat it?

A century and a half ago, the list of effective cancer treatments was essentially a single entry: surgery. Today, in 2026, you’d need pages to contain the number of treatments available, and multiple ...

24 Maalis 1h 32min

Special Episode: Lawrence Ingrassia & A Fatal Inheritance

Special Episode: Lawrence Ingrassia & A Fatal Inheritance

For centuries, physicians noticed that cancer sometimes ran in families, but until the 1960s, an answer to this mystery remained out of reach. Only then were scientists beginning to unlock the cellula...

17 Maalis 45min

Ep 203 Cancer Part 2: Why does it happen?

Ep 203 Cancer Part 2: Why does it happen?

Each of our cells can become cancerous. It’s an uncomfortable, yet unavoidable truth. Nor is it a truth restricted to our species - cancer is a consequence of complex life. The features that make a ce...

10 Maalis 1h 18min

Ep 202 Cancer Part 1: What is it?

Ep 202 Cancer Part 1: What is it?

Cancer has touched every one of us in some capacity, and learning of a diagnosis inspires many more questions than it answers. In this four-part series on cancer, we aim to lay a foundation of knowled...

3 Maalis 1h 36min

Special Episode: Jon Adams and Edmund Ramsden & Rat City

Special Episode: Jon Adams and Edmund Ramsden & Rat City

What happens if you put a bunch of rats in an enclosure and provision them with unlimited food and water? Researcher John B. Calhoun was committed to finding out. Results from Calhoun’s “rat utopia” e...

24 Helmi 56min

Ep 201 Poop Part 2: Flushed away

Ep 201 Poop Part 2: Flushed away

Poop is an incredibly valuable and massively underutilized resource. However, most of us don’t see it that way because of our evolutionarily ingrained disgust towards poop. Flush toilets and intricate...

17 Helmi 1h 21min

Ep 200 Poop Part 1: How the sausage gets made

Ep 200 Poop Part 1: How the sausage gets made

It might be stinky and it might be unpleasant to behold, but we all do it. For many of us, our poop is out of sight, out of mind once we flush it away. But for the next hour and fifteen minutes or so,...

10 Helmi 1h 11min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
tiedekulma-podcast
docemilia
rss-duodecim-lehti
rss-tiedetta-vai-tarinaa
mielipaivakirja
university-of-eastern-finland
utelias-mieli
filocast-filosofian-perusteet
rss-ranskaa-raakana
rss-poliisin-mieli
rss-duokkari-ekstra
rss-astetta-parempi-elama-podcast
rss-ilmasto-kriisissa
rss-pandapodi
rss-lihavuudesta-podcast
rss-sosiopodi